Abstract
Introduction: COVID pandemic keeps threating world population and challenging health services. It is important that each service knows and disseminates its results regarding clinical outcomes.
Objectives: To describe the cases of severe acute respiratory syndrome (SARS) with confirmed infection by Sars-CoV-2, regarding relevant clinical outcomes such as invasive ventilatory support, renal replacement therapy and death in a medium complexity Brazilian hospital.
Methods: Retrospective study: analysis of all notification forms of SARS cases admitted to the University Hospital Lauro Wanderley (HULW) from March 2020 to September 2020 (first wave). Confirmed cases of COVID-19 were considered to be patients who presented detectable Sars-CoV-2 on RT-PCR, serology (positive IgM and / or IgG) and / or rapid test, with compatible symptoms. Only patients aged 18 years or older were included in the study.
Results: 301 patients admitted with SARS were identified, of which 146 met inclusion criteria of the study: 54.1% male, mean age 57.3 years (SD ± 18.4). 80 (54.8%) patients required intensive care, of which 61 (76.3%) underwent invasive mechanical ventilation. Among the patients undergoing intensive care, 37 (46.2%) required renal replacement therapy. 45 (30.1%) patients have died. The total mortality rate was 30.8%. The mortality rate was 70.8% in the population of individuals undergoing invasive mechanical ventilation.
Conclusion: COVID hospitalized patients had a high percentage of complications and enormous demand for ICU services, ventilatory support and hemodialysis.
Footnotes
Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3767.
This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2021
